Radioactive Materials Notification (If Applicable)

This contract requires advance notification to the government if the product or its packaging contains radioactive material, with mandatory disclosure of the specific isotope, activity level, manufacturer details, and associated hazards in compliance with regulatory requirements. The obligation applies solely when radioactive substances are present, and failure to provide timely and accurate information could result in noncompliance or contract breach. The solicitation is issued under the NAICS code 541380 for Medical Supply Chain Pharmaceutical services by the Department of Defense through the MEDICAL SUPPLY CHAIN PHARM FSA, with the place of performance designated as APO 09227-0000. The offer must be submitted by the response deadline of May 18, 2026, and it is classified as a subcontract, though no set-aside designation is specified. The notification process must be initiated immediately upon confirmation of radioactive content to ensure adherence to federal safety and transportation protocols.